Northern Trust
RNTX

Northern Trust’s Rein Therapeutics RNTX Stock Holding History

Northern Trust’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
159,720
+95,584
+149% +$116K ﹤0.01% 3985
2026
Q1 		$83.4K Buy
64,136
+23,667
+58% +$29.4K ﹤0.01% 4144
2025
Q4 		$46.9K Buy
40,469
+14,706
+57% +$20.3K ﹤0.01% 4291
2025
Q3 		$29.5K Hold
25,763
– – ﹤0.01% 4342
2025
Q2 		$36.1K Hold
25,763
– – ﹤0.01% 4282
2025
Q1 		$45.6K Hold
25,763
– – ﹤0.01% 4242
2024
Q4 		$59.3K Hold
25,763
– – ﹤0.01% 4243
2024
Q3 		$91.2K Hold
25,763
– – ﹤0.01% 4080
2024
Q2 		$71.4K Buy
+25,763
New +$106K ﹤0.01% 4128
2022
Q4 		– Sell
-5,690
Closed -$24K – 4718
2022
Q3 		$24K Hold
5,690
– – ﹤0.01% 4516
2022
Q2 		$30K Sell
5,690
-704
-11% -$6.47K ﹤0.01% 4557
2022
Q1 		$65K Hold
6,394
– – ﹤0.01% 4473
2021
Q4 		$72K Hold
6,394
– – ﹤0.01% 4517
2021
Q3 		$130K Hold
6,394
– – ﹤0.01% 4333
2021
Q2 		$160K Hold
6,394
– – ﹤0.01% 4230
2021
Q1 		$183K Buy
6,394
+5,056
+378% +$173K ﹤0.01% 4140
2020
Q4 		$28K Hold
1,338
– – ﹤0.01% 4298
2020
Q3 		$35K Buy
+1,338
New +$31.5K ﹤0.01% 4145
2018
Q2 		– Sell
-906
Closed -$147K – 4334
2018
Q1 		$147K Buy
906
+22
+2% +$3.92K ﹤0.01% 3886
2017
Q4 		$186K Sell
884
-67
-7% -$16.1K ﹤0.01% 3837
2017
Q3 		$254K Buy
+951
New +$239K ﹤0.01% 3723

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Northern Trust's RNTX Position: Q2 2026 in Review

Northern Trust increased its Rein Therapeutics (RNTX) stake by 149% in Q2 2026, buying an estimated $116K and bringing the position to 159,720 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #3985.

Northern Trust first reported a position in RNTX in Q3 2017 and has held it in 21 quarters since. The position peaked at $254K in Q3 2017. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Northern Trust held 159,720 shares of Rein Therapeutics worth $166K as of Q2 2026.
  • Northern Trust bought 95,584 Rein Therapeutics shares in Q2 2026, an estimated $116K.
  • Rein Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3985 holding.
  • Northern Trust first reported a position in Rein Therapeutics in Q3 2017 and has held it in 21 quarters since.
  • Northern Trust's Rein Therapeutics position peaked at $254K in Q3 2017.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.